| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 118 | 137 | 150 | 156 | 172 | 179 | 141 | 203 | 270 | 324 | 402 | 420 |
| Expenses | 104 | 120 | 127 | 130 | 141 | 130 | 109 | 144 | 193 | 228 | 279 | 290 |
| EBITDA | 15 | 17 | 23 | 26 | 31 | 49 | 31 | 59 | 77 | 96 | 124 | 130 |
| Operating Profit % | 12 % | 12 % | 14 % | 15 % | 17 % | 26 % | 22 % | 29 % | 28 % | 29 % | 30 % | 30 % |
| Depreciation | 6 | 9 | 9 | 10 | 11 | 21 | 19 | 20 | 20 | 27 | 40 | 40 |
| Interest | 3 | 4 | 3 | 3 | 3 | 8 | 6 | 6 | 7 | 7 | 13 | 15 |
| Profit Before Tax | 5 | -1 | 11 | 13 | 17 | 20 | 6 | 32 | 49 | 62 | 71 | 75 |
| Tax | -0 | -1 | 4 | 7 | 6 | 6 | 7 | 8 | 13 | 16 | 16 | 16 |
| Net Profit | 6 | 0 | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 46 | 55 | 58 |
| EPS in ₹ | 12.12 | 0.08 | 15.61 | 14.42 | 25.35 | 29.11 | -3.06 | 51.28 | 78.55 | 98.64 | 116.28 | 123.00 |
Dr. Agrawals Eye Hospital
Dr. Agrawals Eye Hospital
4,800.00
-31.40
(-0.65%)
Market Cap
2,259.40 Cr
EPS
116.28
PE Ratio
39.09
Dividend Yield
0.12 %
Industry
Healthcare Services52 Week High
7,300.00
52 Week Low
3,500.00
PB Ratio
10.78
Debt to Equity
1.64
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
Company News
View All News
Dr. Agarwal's Eye Hospital Approves Merger with Parent Company and Preferential Share Allotment
Aug 27, 2025
Aug 27, 2025Dr. Agarwal's Eye Hospital Limited's Board approved a merger scheme with Dr. Agarwal's Health Care Limited through amalgamation by absorption. Under the arrangement, AHCL will issue 23 equity shares for every 2 shares held by the Company's shareholders. The Company will also issue 1,32,827 equity shares to AHCL at ₹5,270 per share through preferential allotment, increasing AHCL's stake from 71.90% to 72.67%. Both companies operate in the eye care hospital business. The merger aims to achieve operational efficiencies, streamlined capital allocation, simplified governance, and shareholder value creation. AHCL had disclosed this merger intention in its IPO prospectus when it listed in February 2025. The Company scheduled its 31st Annual General Meeting for September 24, 2025. All transactions require statutory and regulatory approvals including from stock exchanges, SEBI, shareholders, creditors, and the National Company Law Tribunal.
Dr. Agarwal's Eye Hospital reported a net profit of 173 million rupees for Q1, representing growth from 141 million rupees in the same period last year. The company's revenue increased to 1.17 billion rupees compared to 1 billion rupees year-over-year. Both profit and revenue metrics showed positive year-over-year growth during the quarter.
Dr Agarwals Eye Hospital Reports Q4 Results and Declares DividendMay 28, 2025
Dr Agarwals Eye Hospital has announced its quarterly results and a dividend declaration. The company's Q4 revenue increased to 1 billion rupees from 810 million rupees year-over-year. EBITDA for Q4 rose to 317 million rupees from 244 million rupees, with the EBITDA margin improving to 31.84% from 30.28%. The company's standalone net profit for Q4 grew to 160 million rupees from 128 million rupees in the previous year. Additionally, the company has declared a dividend of 3.5 rupees per share.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,123.40 | #1 1,09,211.00 | 91.03 | 7,184.10 | #1 28.68 | 1,076 | 30.34 | 38.75 | |
7,510.00 | 1,07,982.30 | 68.57 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 42.87 | |
932.75 | 70,418.70 | 76.18 | 7,849.70 | 13.25 | 809 | #1 53.33 | 50.92 | |
1,725.00 | 35,252.20 | #1 44.56 | 5,575.00 | 12.29 | 790 | -2.38 | 39.23 | |
1,299.70 | 34,908.30 | 61.28 | 3,771.40 | 12.59 | 481 | 49.58 | 43.43 | |
625.10 | 32,387.70 | 90.59 | 4,286.70 | 15.12 | 337 | -98.18 | 58.09 | |
726.70 | 29,078.10 | 78.90 | 3,067.00 | 21.98 | 415 | -10.71 | 45.36 | |
1,361.80 | 13,829.30 | 53.71 | 1,566.90 | 17.46 | 244 | 35.52 | 24.06 | |
1,510.40 | 9,903.10 | 51.34 | 1,290.20 | 17.77 | 194 | -1.57 | 70.90 | |
647.40 | 9,025.80 | 244.98 | 2,257.70 | 17.03 | 49 | -55.88 | 46.29 |
Forecast
Actual
Growth Rate
Revenue Growth
24.02 %
Net Income Growth
17.67 %
Cash Flow Change
5.25 %
ROE
-11.63 %
ROCE
-4.42 %
EBITDA Margin (Avg.)
3.78 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 |
| Fixed Assets | 27 | 34 | 33 | 36 | 55 | 94 | 96 | 214 | 260 | 316 | 393 |
| Current Assets | 23 | 24 | 20 | 23 | 30 | 30 | 44 | 50 | 47 | 60 | 56 |
| Capital Work in Progress | 0 | 1 | 1 | 3 | 0 | 0 | 0 | 27 | 62 | 97 | 128 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 |
| Other Assets | 43 | 44 | 38 | 42 | 45 | 47 | 60 | 73 | 67 | 83 | 80 |
| Total Liabilities | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 |
| Current Liabilities | 31 | 36 | 27 | 37 | 35 | 39 | 49 | 53 | 55 | 81 | 87 |
| Non Current Liabilities | 15 | 19 | 16 | 9 | 19 | 45 | 52 | 183 | 222 | 258 | 317 |
| Total Equity | 24 | 23 | 29 | 35 | 46 | 56 | 55 | 78 | 113 | 157 | 210 |
| Reserve & Surplus | 19 | 19 | 25 | 30 | 41 | 51 | 50 | 74 | 109 | 152 | 205 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 0 | 0 | -1 | 2 | 2 | 15 | 7 | -1 | 6 | -22 |
| Investing Activities | -10 | -17 | -8 | -11 | -25 | -17 | -11 | -46 | -71 | -70 | -133 |
| Operating Activities | 14 | 17 | 20 | 19 | 25 | 39 | 34 | 57 | 70 | 90 | 95 |
| Financing Activities | -5 | -0 | -12 | -8 | 2 | -20 | -8 | -4 | 0 | -14 | 17 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 74.02 % | 73.77 % | 73.60 % | 72.38 % | 72.15 % | 72.00 % | 71.91 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.28 % | 0.00 % | 0.64 % | 0.65 % | 0.83 % | 0.84 % | 1.33 % | 1.50 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.96 % | 1.03 % | 1.95 % | 2.31 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 21.77 % | 22.07 % | 22.23 % | 23.32 % | 23.55 % | 23.63 % | 23.24 % | 22.80 % | 22.65 % | 22.66 % | 22.15 % | 21.84 % | 21.74 % | 21.77 % | 20.51 % | 20.44 % | 19.25 % | 18.95 % |
| Others | 4.21 % | 4.16 % | 4.17 % | 4.30 % | 4.30 % | 4.37 % | 4.86 % | 5.31 % | 5.46 % | 5.45 % | 5.67 % | 6.27 % | 5.72 % | 5.69 % | 5.80 % | 5.79 % | 5.57 % | 5.34 % |
| No of Share Holders | 2,492 | 2,462 | 2,444 | 2,741 | 2,764 | 2,791 | 2,858 | 3,006 | 3,110 | 3,169 | 3,471 | 3,423 | 3,572 | 3,808 | 4,510 | 15,115 | 41,704 | 35,976 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1.5 | 1.2 | 1.5 | 0.00 | 0.00 | 3 | 3 | 2.5 | 6 |
| Dividend Yield (%) | 0.00 | 0.25 | 0.33 | 0.79 | 0.00 | 0.00 | 0.33 | 0.1 | 0.06 | 0.12 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2022 |  Dividend | ₹ 3.00 /share | 06 Sept 2022 | 735.10 | 1,077.00 |
| 15 Sept 2023 | Dividend | ₹ 3.00 /share | 14 Sept 2023 | 1,161.90 | 2,383.25 |
| 31 Oct 2023 | Dividend | ₹ 2.50 /share | 31 Oct 2023 | 2,952.15 | 2,777.00 |
| 20 Aug 2024 | Dividend | ₹ 2.50 /share | 19 Aug 2024 | 3,550.75 | 4,050.35 |
| 26 Aug 2024 |  Annual General Meeting | NA | 26 Aug 2024 | 4,000.65 | 4,004.90 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 5,298.15 | 5,216.10 |
| 08 Nov 2024 | Dividend | ₹ 2.50 /share | 08 Nov 2024 | 5,216.10 | 5,229.45 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 4,361.05 | 4,148.75 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 4,275.65 | 4,375.65 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 4,393.45 | 4,424.65 |
| 18 Sept 2025 | Dividend | ₹ 3.50 /share | 18 Sept 2025 | 4,375.65 | 4,653.40 |
| 24 Sept 2025 | Annual General Meeting | NA | 24 Sept 2025 | 5,145.65 | 4,746.50 |
Announcements
Closure of Trading Window1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Allotment1 day ago
1 day agoShareholder Meeting / Postal Ballot-Scrutinizers Report2 days ago
2 days agoShareholder Meeting / Postal Ballot-Outcome of AGM3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationSep 16, 2025
Sep 16, 2025Corrigendum To The Notice Of The 31St Annual General Meeting To Be Held On Wednesday September 24 2025 At 10 A.M.Sep 15, 2025
Sep 15, 2025Newspaper Advertisement-31St Annual General Meeting And Information On E-Voting And Other Related InformationSep 03, 2025
Sep 03, 2025Corporate Action-Record Date For Final Dividend- September 18 2025Sep 02, 2025
Sep 02, 2025Shareholders Meeting On September 24 2025Sep 02, 2025
Sep 02, 2025Reg. 34 (1) Annual Report.Sep 02, 2025
Sep 02, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 27, 2025
Aug 27, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated August 27 2025Aug 27, 2025
Aug 27, 2025Board Meeting Intimation for Considering The Proposal To Raise Funds By Issuance Of Equity Shares Of The Company To Dr. Agarwals Health Care Limited (Promoter Of The Company) By Way Of Preferential AllotmentAug 24, 2025
Aug 24, 2025Results- Financial Results For June 30 2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for For Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Credit RatingJul 30, 2025
Jul 30, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025Jul 30, 2025
Jul 30, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Jul 04, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Corporate Action-Board approves DividendMay 28, 2025
May 28, 2025Audited Results-31-03-2025May 28, 2025
May 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting Dated May 28 2025May 28, 2025
May 28, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
May 23, 2025Board Meeting Intimation for Intimation Of Date Of Board MeetingMay 20, 2025
May 20, 2025Announcement Under Regulation 30 Of SEBI (LODR) RegulationsApr 25, 2025
Apr 25, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Apr 05, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Commencement Of Operation Of A New BranchMar 19, 2025
Mar 19, 2025Announcement Under Regulation 30(5) Of SEBI (LODR) Regulations 2015- Commencement Of Operation Of A New BranchMar 03, 2025
Mar 03, 2025Announcement under Regulation 30 (LODR)-Credit RatingFeb 17, 2025
Feb 17, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Announcement Under Regulation 30(5) Of SEBI (LODR) Regulations 2015Feb 14, 2025
Feb 14, 2025Results- Financial Results For The Quarter And Nine Months Ended 31-12-2024Feb 14, 2025
Feb 14, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Feb 14, 2025Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Nine-Months Ended December 31 2024Feb 07, 2025
Feb 07, 2025Clarification On Price MovementJan 30, 2025
Jan 30, 2025Clarification sought from Dr Agarwals Eye Hospital LtdJan 29, 2025
Jan 29, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jan 24, 2025
Jan 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015- Commencement Of Operation Of A New BranchDec 27, 2024
Dec 27, 2024Closure of Trading WindowDec 27, 2024
Dec 27, 2024Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Commencement Of Operation Of A New BranchDec 13, 2024
Dec 13, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 05, 2024
Dec 05, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 05, 2024
Dec 05, 2024Shareholder Meeting / Postal Ballot-Scrutinizers ReportDec 02, 2024
Dec 02, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 29, 2024
Nov 29, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 19, 2024
Nov 19, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 15, 2024
Nov 15, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 12, 2024
Nov 12, 2024Technical Indicators
RSI(14)
Neutral 62.05
ATR(14)
Less Volatile 142.75
STOCH(9,6)
Neutral 67.04
STOCH RSI(14)
Overbought 93.51
MACD(12,26)
Bullish 15.52
ADX(14)
Strong Trend 28.00
UO(9)
Bearish 51.17
ROC(12)
Uptrend And Accelerating 5.18
WillR(14)
Overbought -18.08
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 0.76% | 1386 | 0.14% | 0.14% | |
 PGIM India Healthcare Fund Direct-Growth | 0.49% | 0 | 0.03% | 0.26% | |
| PGIM India Retirement Fund Direct - Growth | 0.22% | 0 | 0.01% | 0.00% |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
